Is Dbv Technologies SA halal to invest in?

According to Musaffa's Shariah screening methodology, Dbv Technologies SA (DBV.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Dbv Technologies SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Dbv Technologies SA using these criteria to determine its compliance status.

Can Muslims buy shares of Dbv Technologies SA?

Muslim investors may consider investing in Dbv Technologies SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Dbv Technologies SA classified as NOT HALAL?

Musaffa determines the Shariah status of Dbv Technologies SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Dbv Technologies SA updated?

The Shariah compliance status of Dbv Technologies SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Dbv Technologies SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Dbv Technologies SA?

You can check the latest Shariah compliance status of Dbv Technologies SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Dbv Technologies SA DBV.PA

€3.37 €0.04 (1.06%) 1D

Last Updated: May 15, 12:00 AM·XPAR

DBV.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 02, 2026

Report Source: 2025 Annual Report

Dbv Technologies SA. Stock Analysis DBV.PA

France Health Care Small Cap Report: 2025 Annual

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The company is headquartered in Chatillon, Auvergne-Rhone-Alpes and currently employs 125 full-time employees. The company went IPO on 2012-03-29. The firm's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. The company dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The firm's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The firm operates one subsidiary DBV Technologies Inc. in the United States.

Key Statistics of Dbv Technologies SA (DBV.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€3.35€3.47

Today's Open

€3.41

Volume

109.58K

P/E Ratio (TTM)

52 Week Range

€1.30€4.50

Market Cap

934.51M

Avg. Volume

425.55K

Dividend Yield

Financial Metrics & Statements of Dbv Technologies SA (DBV.PA)

FAQ's for Dbv Technologies SA (DBV.PA)

According to Musaffa’s Shariah screening methodology, Dbv Technologies SA (DBV.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.